Earnings
CRSP
188.68
+1.93%
3.58
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
943.77M
--
--
99.00K
--
--
0.00
--
--
--
43.68M
--
987.55M
72.83M
--
--
--
--
235.00K
--
6.14M
79.20M
1.07B
--
5.94M
0.00
--
--
--
--
--
38.67M
--
--
--
12.49M
57.11M
0.00
--
--
--
70.22M
70.22M
127.33M
1.85M
1.16B
-224.71M
-63.00K
--
--
939.42M
939.42M
1.07B
FY 2018-12-31
456.65M
--
--
88.00K
--
--
0.00
--
--
--
9.66M
--
466.39M
18.50M
--
--
--
--
289.00K
--
3.83M
22.62M
489.02M
--
5.07M
0.00
--
--
--
--
--
20.85M
--
--
--
1.82M
27.75M
0.00
--
--
--
69.08M
69.08M
96.82M
1.58M
682.25M
-291.57M
-57.00K
--
--
392.19M
392.19M
489.02M
FY 2017-12-31
239.76M
--
--
2.63M
--
--
0.00
--
--
--
6.00M
--
248.38M
18.86M
--
--
--
--
344.00K
--
3.76M
22.96M
271.35M
--
1.64M
0.00
--
--
--
--
--
11.36M
--
--
--
1.51M
14.51M
0.00
--
--
--
69.00M
69.00M
83.51M
1.24M
312.02M
-125.44M
0.00
--
--
187.83M
187.83M
271.35M
FY 2016-12-31
315.52M
--
--
3.16M
--
--
0.00
--
--
--
1.51M
--
320.19M
21.03M
--
--
--
--
399.00K
--
3.35M
24.77M
344.96M
--
4.57M
0.00
--
--
--
--
--
16.32M
--
--
--
1.11M
22.00M
0.00
--
--
--
90.12M
90.12M
112.12M
1.22M
288.74M
-57.08M
0.00
--
0.00
232.85M
232.85M
344.96M
FY 2015-12-31
155.96M
--
--
339.00K
--
--
0.00
--
--
--
540.00K
--
156.84M
1.33M
--
0.00
--
--
454.00K
--
801.00K
2.58M
159.42M
--
1.58M
0.00
--
--
--
--
--
8.43M
--
--
--
141.00K
10.15M
38.34M
--
--
--
75.53M
113.84M
124.03M
181.00K
4.64M
-33.91M
0.00
--
-27.00K
35.42M
35.40M
159.42M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CRSP latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Crispr Therapeut recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.